Invista (Wichita, Kan.; www.invista.com) and its partner have decided to deploy Invista’s most advanced adiponitrile (ADN) technology at the Butachimie joint venture in France. Owned by Invista and Solvay, Butachimie is the largest ADN facility in the world. Invista’s new technology will be implemented by retrofitting the existing facilities during a planned turnaround in the second quarter of 2019.
The new technology, already deployed and proven at Invista’s facility in Orange, Texas, extends Invista’s market-leading ADN technology in several aspects, including improved product yields, reduced energy consumption, lower greenhouse gas emissions, enhanced process stability and reduced capital intensity, compared to existing technologies.
“The performance of this technology at Orange has exceeded our expectations and we look forward to the benefits that deployment at additional facilities will bring to the marketplace,” said Bill Greenfield, president, Invista Intermediates. “Since beginning commercial operation of this technology in 2014, we’ve demonstrated improved yield, reliability and record production rates at Orange.”